Department of Health Policy Jefferson Medical College

1
Department of Health PolicyJefferson Medical
College

• David B. Nash, MD, MBA
• University of the Sciences in Philadelphia
• September 27, 2006

2
Peter Chodoff, MD, MPH Max Koppel, MD,
MPH Resident Senior Scholars
David B. Nash, MD, MBA Department Chair
David Glatter, MBA Department Administrator
Elizabeth Lopez Office Manager
Maxine Rosen Admin Assistant
Darlene Moragne-Sheaff Admin Assistant
Jeannine Kinney Grants Manager
Neil Goldfarb Program Director, Research
Alexandria Skoufalos, EdD Program Director,
Education
3
(No Transcript)
4
Alexandria Skoufalos, EdD Program Director,
Education
Grace Hershman Project Director
5
Research Program

• Program Director
• Neil I Goldfarb

6
Overview

• Research Program Structure
• Life Cycle of a Typical DHP Project
• Samples of Recent Projects

7
Research Funding Sources Current Grants
(1,000s)
8
Quality of Care Research

• Use of the ABIM PIM in group practice
• JUP CCC departmental projects
• Development of a migraine quality measurement set
• Measuring and improving LTC quality
• Appropriate prescribing for the elderly
• Use of HIT to improve hospital quality
• Evaluation of managed care QI interventions

9
Health Policy/Population Health

• Colorectal cancer screening in PA
• Evaluation of web-based residency training on
  headache
• GERD knowledge and attitudes in minority
  populations
• Improving Rx access for the underserved

10

• The College for Advanced Management of Health
  Benefits
• Collaboration with NBCH and HC21 Business
  Coalition
• Trains employee benefit managers on how to take a
  value-based approach to purchasing health
  benefits
• 6 cohorts trained so far. Final 2006 program
  9/18-9/21 in Charlotte NC
• VBP e-journal available at http//jdc.jefferson.ed
  u/vbp

11
Pharmacoeconomics and Outcomes Research

• A Summary of Activities and Key Accomplishments
• 2005-2006

12
Areas of Research Expertise

• Pharmacoeconomics
• Economic Modeling (e.g., cost-effectiveness,
  budget impact of pharmaceuticals as well as
  non-drug interventions)
• Cost and/or burden of illness analyses

• Outcomes Research
• Quality of life
• Work productivity
• Risk adjustment methods using pharmaceutical data
• Instrument development

13
Examples of Current Projects

• Development of an economic model for an Academy
  of Managed Care (AMCP) Dossier for a urologic
  drug
• Estimation of the extent of inappropriate
  medication prescribing for elderly ambulatory
  patients, and to help design educational
  activities to improve physicians' prescribing in
  Parma, Italy
• Design and analysis of productivity data from a
  large prospective multi-center U.S. study
• Design, conduct, and analysis of a prospective
  study on the costs of breakthrough pain

14
Examples of Current Projects

• Pooled analysis of productivity data collected
  alongside 3 randomized, controlled clinical
  trials of a migraine medication
• Examination of the costs of non-adherence to a
  guideline for treating anemia in hemodialysis
  patients
• Cost of illness study of candidemia in
  hospitalized patients
• Measurement of quality of life in patients with
  cystinurea compared with traditional kidney
  stones
• Evaluation of the impact of a federal
  pharmaceutical assistance program on the
  uninsured and underinsured in Philadelphia

15
Key Accomplishments

• Best New Investigator Podium Presentation, ISPOR
  International Meeting, May 2005 (V. Maio)
• Best Podium Presentation, ISPOR European
  Congress, Nov 2005 (L. Pizzi)
• Intramural Award for Preventing Medical Errors in
  Child Care (J. Lofland with C. Hartmann)
• Intramural Award for Reducing Inappropriate
  Prescribing in the Elderly (C. Hartmann with V.
  Maio)
• Article entitled, Pharmacy Utilization and the
  Medicare Modernization Act in The Milbank
  Quarterly  2005 was selected for inclusion in the
  prestigious Database of Abstracts of Reviews of
  Effects (DARE) maintained by the Center for
  Reviews and Dissemination (CDR) at The University
  of York, UK. (V. Maio and L. Pizzi with N.
  Goldfarb and D. Nash)

16
Our Strengths

• Combined years of PE/OR experience 26
• Understanding of the methods
• Familiar with advantages and disadvantages of
  various data sources
• Understanding of how PE/OR fits into healthcare
  decision-making
• Recognized as leaders in the field
• Concerned about academic integrity
• Experience in working with a variety of clients
  to investigate PE/OR issues
• Manufacturers (pharmaceutical, device, biotech)
• Healthcare providers
• Health plans
• We are real people!

17
EducationProgram

• Program Director
• Alexis Skoufalos, EdD

18
Products and Services

• Advisory Boards
• Education and Training Programs
• Publications
• Specialized Services
• Special Issues Boards
• Evaluation of Products and Processes
• Development of White Papers and Manuscripts
• CPE and CME credit

19
Advisory Boards

• Strategic
• Product/Service roll-out
• Marketing and Finance
• Policy
• Product Evaluation
• Clinical
• Evidence-based guidelines
• Use and effectiveness
• Policy
• Quality and Performance Improvement

20
Education and Training Programs

• Ongoing (open to all)
• Grandon Lecture (May)
• Summer Seminar (July)
• Health Policy Forum (Sep. June)

• University (for students and faculty)
• Interclerkship Day (January)
• Preclerkship Day (July)

21
Education and Training Programs (contd)

• Professional Conferences
• Disease Management Colloquium (May)
• Medical Education Symposium (November)

• Customized Workshops and Industry Training
• Radiology Utilization
• Evidence-Based Medicine
• Smoking Cessation (conference and Website)
• Leadership and Executive Education
• Quality Improvement
• Clinical Training for Pharmaceutical Reps

22
PublicationsAmerican Journal of Medical Quality

• Journal of the American College of Medical
  Quality
• Bimonthly
• Peer-reviewed
• Target Audience health care professionals
  involved in medical quality management
• Index Medicus/MEDLINE, EMBASE/Excerpta
• Circulation 1400
• http//ajm.sagepub.com (FREE online through
  8/31/06)

David B. Nash, MD, MBA Editor-in-Chief
23
PublicationsDisease Management

• Official Journal of the Disease Management
  Association of America
• Bimonthly
• Peer-reviewed
• Target Audience health care professionals
  involved in managed care and disease management
• Index Medicus/MEDLINE, EMBASE/Excerpta Medica
• Circulation 1200
• www.dmaa.org/dmho.html

David B. Nash, MD, MBA Editor
24
PublicationsPT

• Monthly
• Peer-reviewed
• Target Audience Managed care executives,
• PT Committee members and healthcare
  professionals
• EMBASE, International Pharmaceutical Abstracts
• Circulation 48,000
• CPE and CME credit available
• www.formkit.com/ptJournal/journalView.cfm

David B. Nash, MD, MBA Editor-in-Chief
25
PublicationsBiotechnology Healthcare

• Bimonthly
• Peer-reviewed
• Target Audience health care professionals and
  others involved in economic, coverage, and policy
  issues relative to biotech therapies,
  diagnostics, and devices
• Index Medicus/MEDLINE, EMBASE/Excerpta Medica
• Circulation 35,000
• www.biotechnologyhealthcare.com

David B. Nash, MD, MBA Editor-in-Chief, Editorial
Advisory Board
26
PublicationsHealth Policy Newsletter

• Quarterly
• Target Audience healthcare professionals and
  others involved in economic, coverage, and policy
  issues
• Circulation 35,000
• www.jefferson.edu/dhp/newsletter.cfm
• or jdc.jefferson.edu/hpn/

David B. Nash, MD, MBA Editor-in-Chief
27
PublicationsBooks
28
PublicationsBooks

• Currently managing the editorial production of
  Practicing Medicine in the 21st Century for the
  American College of Physician Executives

29
Future Plans

• Increased use of technology, both to publicize
  projects and initiatives and to make them more
  accessible
• Podcasting
• Online resources and programs

30
In Conclusion

• Increase collaborations with other schools and
  organizations
• Expand the departments reach and research to
  address issues relevant to national and local
  health policy
• Foster relationships with clients and colleagues
  to improve knowledge on key health issues